[一个三十多岁的女性,经常出现粘膜]
Helle Bitter1, Øyvind Midtvedt2, Ragnar Gunnarsson2
1Revmatologisk seksjon, Medisinsk avdeling, Sørlandet sykehus.
哈普洛因缺乏症A20 (HA20) 是一种由TNFAIP3/A20突变引起的新发现的自身炎症性疾病. 基因检测显示,这种遗传性疾病在受影响的家庭中模仿贝切特病的症状.
科学领域:
- 遗传学 是一个遗传学.
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 哈普洛因缺乏症A20 (HA20) 是一种自发炎症性疾病,在2016年被发现.
- 它是由TNFAIP3/A20基因的突变引起的.
- 这种情况呈现出类似于贝赫塞特病的症状.
更多相关视频
07:05Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
相关概念视频
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Disorders of the Female Reproductive System
